3,4-Methylenedioxyphentermine
Names | |
---|---|
IUPAC name
1-(1,3-Benzodioxol-5-yl)-2-methylpropan-2-amine | |
Other names
3,4-Methylenedioxyphentermine; 3,4-Methylenedioxy-alpha,alpha-dimethyl-1-ethane | |
Identifiers | |
39235-63-7 | |
3D model (Jmol) | Interactive image |
ChemSpider | 15204207 |
| |
| |
Properties | |
C11H15NO2 | |
Molar mass | 193.25 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
3,4-Methylenedioxyphentermine (MDPH) is a lesser-known psychedelic drug. MDPH was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 160–240 mg, and the duration as 3–5 hours.[1] MDPH's effects are very similar to those of MDA: they both are smooth and "stoning," and do not cause any visuals. They also alter dreams and dream patterns. Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to 2C-D. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.
See also
References
This article is issued from Wikipedia - version of the 8/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.